Effective planning begins with grading VMS severity, characterizing the sleep complaint, and confirming hormone therapy ...

Limited visit time, minimal sleep medicine training, and widespread self-medication leave many women with menopause-related ...

Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 ...

One question at every visit could prevent strokes in atrial fibrillation, says Geoffrey Barnes, MD, who also previews ...

Annual injections, every-4-month dosing, and a once-monthly pill could reshape HIV prevention. Yet the faculty agree the most ...

The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults ...

Linda Bradley, MD, explains why blind endometrial sampling may miss focal uterine pathology and when persistent abnormal ...

October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart ...

Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank ...

Pauline M. Maki, PhD, discusses how the boxed-warning removal for hormone therapy and an expanding class of neurokinin-targeted therapies broaden options, and shares her key takeaway from OPTION-VMS.

Patient Care Online offers clinical news and resources for primary care clinicians, focusing on disease states, guidelines, and trends to improve care.